Operose Advisors’s Incyte INCY Stock Holding History

Operose Advisors’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10	Closed	-$941	–	604
2026 Q1	$941	Buy	+10	New	+$998	﹤0.01%	542

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Operose Advisors's INCY Position: Q2 2026 in Review

Operose Advisors sold out of Incyte (INCY) in Q2 2026, closing a stake of 10 shares — an estimated $941 sold.

Operose Advisors first reported a position in INCY in Q1 2026 and held it in 1 quarter. The position peaked at $941 in Q1 2026. 858 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

Operose Advisors reported no remaining Incyte position as of Q2 2026 after selling out during the quarter.
Operose Advisors sold 10 Incyte shares in Q2 2026, an estimated $941.
Operose Advisors first reported a position in Incyte in Q1 2026 and held it in 1 quarter.
Operose Advisors's Incyte position peaked at $941 in Q1 2026.
858 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.